17.12.2012 Views

crc press - E-Lib FK UWKS

crc press - E-Lib FK UWKS

crc press - E-Lib FK UWKS

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Index 403<br />

pRB proteins, Tat-E1A binding of, 370<br />

Predictive and proteome analyses, 310–313<br />

artificial neural network-based methods,<br />

311–312<br />

global structure-based methods, 312–313<br />

prediction algorithms, 310<br />

from proteome to secretome, 313<br />

weight matrix methods, 311<br />

Proline-rich peptides as translocating, 130<br />

Protein fibroblast growth factor-1 (FGF-1), 119<br />

Proteins, transportan and, 61–66<br />

Protein transport, 365–375<br />

delivery of PTD-conjugated macromolecules,<br />

369–373<br />

applications in cell culture, 369–371<br />

applications in vivo, 371–373<br />

development of PTD fusion proteins,<br />

367–369<br />

cloning and purification of Tat fusion<br />

proteins, 368–369<br />

principles of protein transduction, 365–366<br />

protein transduction technology, 366–367<br />

Proteome analyses, 310–313<br />

artificial neural network-based methods,<br />

311–312<br />

global structure-based methods, 312–313<br />

prediction algorithms, 310<br />

from proteome to secretome, 313<br />

weight matrix methods, 311<br />

PR-39 protein, 129<br />

pVEC, 356<br />

Q<br />

Quantification, 263–275<br />

of CPPs via reporter groups, 266–272<br />

biotinylation and cell-ELISA, 267<br />

enzyme activity assays, 270<br />

fluorescence microscopy, spectrometry,<br />

and FACS, 267–269<br />

fluorogenic construct assay (resonance<br />

energy transfer, RET quenching),<br />

270–272<br />

fluorogenic construct assay (resonance<br />

energy transfer, RET),<br />

270–272<br />

HPLC detection, 269–270<br />

immunodetection, 270<br />

radiolabeling, 266–267<br />

of peptide cargo bioactivity, 272–274<br />

DNA/PNA antisense effects, 273<br />

drug activity, 273–274<br />

epidermal growth factor receptor (EGFR),<br />

272–273<br />

principles and background, 263–266<br />

R<br />

Rac GTPases, 370<br />

Radiolabeling<br />

quantification by, 266–267<br />

for uptake kinetics assays, 280–281<br />

125 I-radiolabeling, for uptake kinetics assays,<br />

280–281<br />

Reagents, for solution phase conjugation, 332–336<br />

amine-reactive reagents, 332–333<br />

example: superparamagnetic iron oxide<br />

particle–Tat conjugate, 334–336<br />

heterobifunctional conjugation, 333–334<br />

sulfhydryl-reactive reagents, 333<br />

Receptors, internalization by, 177–179<br />

Resonance energy transfer (RET) quenching,<br />

quantification by, 270–272<br />

Rhodamine membrane uptake assay, 251–252<br />

Rho GTPases, 370<br />

S<br />

Sec6α, 304<br />

Sec61β, 304<br />

Sec61gamma, 304<br />

SecA-dependent bacterial protein secretion<br />

pathways, 299<br />

SecA protein, 299<br />

SecB-dependent bacterial protein secretion<br />

pathways, 298–299<br />

SecB protein, 297–298<br />

SecDFyajC protein, 300<br />

SecE protein, 300<br />

SecG protein, 300<br />

Sec62p, 304<br />

Sec63p, 304–305, 305<br />

Sec71p, 304<br />

SecYEG and related protein-dependent bacterial<br />

protein secretion pathways, 300<br />

SecYEG channel, 297<br />

SecYEG protein, 300<br />

SecY (PrlA) protein, 300<br />

Side effects, 255–256, see also Toxicity<br />

Tat, 256<br />

transportan, 255–256<br />

Signal anchors, 306<br />

Signal peptidases, 306–308<br />

PiHD (XcpA), 307<br />

type I<br />

distribution, 306<br />

specificity, 307<br />

type II, 307<br />

Signal peptides, 295–324<br />

bacterial protein secretion pathways, 297–303<br />

Ffh and 4.5S RNA-dependent, 300–301

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!